Abstract
Peptide nucleic acids (PNA) are artificial structural mimics of nucleic acids capable of sequence specific hybridization to both RNA and DNA. Thus they have obvious potential as gene targeting agents for drug discovery approaches. An overview with emphasis on recent progress on RNA “interference” (antisense), targeting of duplex DNA and gene targeted repair and transcription interference using PNA, as well as on PNA delivery and potential PNA anti-infectives is given.
Keywords: Gene targeting, antisense, PNA, delivery, transcription
Current Pharmaceutical Design
Title: Gene Targeting and Expression Modulation by Peptide Nucleic Acids (PNA)
Volume: 16 Issue: 28
Author(s): Peter E. Nielsen
Affiliation:
Keywords: Gene targeting, antisense, PNA, delivery, transcription
Abstract: Peptide nucleic acids (PNA) are artificial structural mimics of nucleic acids capable of sequence specific hybridization to both RNA and DNA. Thus they have obvious potential as gene targeting agents for drug discovery approaches. An overview with emphasis on recent progress on RNA “interference” (antisense), targeting of duplex DNA and gene targeted repair and transcription interference using PNA, as well as on PNA delivery and potential PNA anti-infectives is given.
Export Options
About this article
Cite this article as:
E. Nielsen Peter, Gene Targeting and Expression Modulation by Peptide Nucleic Acids (PNA), Current Pharmaceutical Design 2010; 16 (28) . https://dx.doi.org/10.2174/138161210793292546
DOI https://dx.doi.org/10.2174/138161210793292546 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
New Drug Targets for Hepatitis C and Other Flaviviridae Viruses
Infectious Disorders - Drug Targets Treatment of Epileptic Encephalopathies
Current Pharmaceutical Design Disorders of Consciousness and Pharmaceuticals that Act on Oxygen Based Amino Acid and Monoamine Neurotransmitter Pathways of the Brain
Current Pharmaceutical Design Par-4 for Molecular Therapy of Prostate Cancer
Current Drug Targets Impact of HIV on Regional & Cellular Organisation of the Brain
Current HIV Research Humanized Mouse Models of HIV-1 Latency
Current HIV Research Proinflammatory Cytokines and Chemokines in Neonatal Brain Damage
Current Pediatric Reviews A Systematic Approach to Hypertensive Urgencies and Emergencies
Current Hypertension Reviews Approaches to the Pharmacological Modulation of Plasmacytoid Dendritic Cells
Endocrine, Metabolic & Immune Disorders - Drug Targets Antiidiotype-Derived Killer Peptides As New Potential Tools to Combat HIV-1 and AIDS-Related Opportunistic Pathogens
Anti-Infective Agents in Medicinal Chemistry Inhibition of Membrane Fusion as a Target for Antiviral Therapy
Anti-Infective Agents in Medicinal Chemistry The Microbiota and Gut-Brain Axis: Contributions to the Immunopathogenesis of Schizophrenia
Current Pharmaceutical Design Neurotrophic Factors - A Tool for Therapeutic Strategies in Neurological,Neuropsychiatric and Neuroimmunological Diseases?
Current Medicinal Chemistry Players in ADP-ribosylation: Readers and Erasers
Current Protein & Peptide Science The Multiple Layers of Signaling Selectivity at Protease-Activated Receptors
Current Pharmaceutical Design Infectious Agents and Neurodegenerative Diseases: Exploring the Links
Current Topics in Medicinal Chemistry Down Regulated Expression of Claudin-1 and Claudin-5 and Up Regulation of β-Catenin: Association with Human Glioma Progression
CNS & Neurological Disorders - Drug Targets Radiotracers for Molecular Imaging of Cyclooxygenase-2 (COX-2) Enzyme
Current Medicinal Chemistry New Perspectives in HCV Therapy: Entry Inhibitors
Recent Patents on Anti-Infective Drug Discovery Inflammatory Process in Parkinsons Disease: Role for Cytokines
Current Pharmaceutical Design